Literature DB >> 15592458

Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP.

Elina Mattila1, Teijo Pellinen, Jonna Nevo, Karoliina Vuoriluoto, Antti Arjonen, Johanna Ivaska.   

Abstract

Integrin-mediated cell adhesion regulates a multitude of cellular responses, including proliferation, survival and cross-talk between different cellular signalling pathways. So far, integrins have been mainly shown to convey permissive signals enabling anchorage-dependent receptor tyrosine kinase signalling. Here we show that a collagen-binding integrin alpha(1)beta(1) functions as a negative regulator of epidermal growth factor receptor (EGFR) signalling through the activation of a protein tyrosine phosphatase. The cytoplasmic tail of alpha(1) integrin selectively interacts with a ubiquitously expressed protein tyrosine phosphatase TCPTP (T-cell protein tyrosine phosphatase) and activates it after cell adhesion to collagen. The activation results in reduced EGFR phosphorylation after EGF stimulation. Introduction of the alpha(1) cytoplasmic domain peptide into cells induces phosphatase activation and inhibits EGF-induced cell proliferation and anchorage-independent growth of malignant cells. These data are the first demonstration of the regulation of TCPTP activity in vivo and represent a new molecular paradigm of integrin-mediated negative regulation of receptor tyrosine kinase signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592458     DOI: 10.1038/ncb1209

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  77 in total

1.  Vascular endothelial growth factor A (VEGF-A) induces endothelial and cancer cell migration through direct binding to integrin {alpha}9{beta}1: identification of a specific {alpha}9{beta}1 binding site.

Authors:  Saji Oommen; Shiv K Gupta; Nicholas E Vlahakis
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

2.  Spermidine stimulates T cell protein-tyrosine phosphatase-mediated protection of intestinal epithelial barrier function.

Authors:  Harrison M Penrose; Ronald R Marchelletta; Moorthy Krishnan; Declan F McCole
Journal:  J Biol Chem       Date:  2013-09-10       Impact factor: 5.157

3.  Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells.

Authors:  Dong-Wan Seo; Hongmei Li; Cheng-Kui Qu; Junseo Oh; Young-Sik Kim; Tere Diaz; Beiyang Wei; Jeung-Whan Han; William G Stetler-Stevenson
Journal:  J Biol Chem       Date:  2005-12-02       Impact factor: 5.157

Review 4.  The role of integrins in the trabecular meshwork.

Authors:  Debjani Gagen; Jennifer A Faralli; Mark S Filla; Donna M Peters
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-23       Impact factor: 2.671

5.  Inhibitors of myelination: ECM changes, CSPGs and PTPs.

Authors:  Danielle E Harlow; Wendy B Macklin
Journal:  Exp Neurol       Date:  2013-11-04       Impact factor: 5.330

6.  Inhibition of integrin-mediated crosstalk with epidermal growth factor receptor/Erk or Src signaling pathways in autophagic prostate epithelial cells induces caspase-independent death.

Authors:  Mathew J Edick; Lia Tesfay; Laura E Lamb; Beatrice S Knudsen; Cindy K Miranti
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

7.  Wedelolactone, a naturally occurring coumestan, enhances interferon-γ signaling through inhibiting STAT1 protein dephosphorylation.

Authors:  Zhimin Chen; Xiaoxiao Sun; Shensi Shen; Haohao Zhang; Xiuquan Ma; Jingli Liu; Shan Kuang; Qiang Yu
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

8.  Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.

Authors:  L Wu; J A Bernard-Trifilo; Y Lim; S-T Lim; S K Mitra; S Uryu; M Chen; C J Pallen; N-Kv Cheung; D Mikolon; A Mielgo; D G Stupack; D D Schlaepfer
Journal:  Oncogene       Date:  2007-09-10       Impact factor: 9.867

9.  An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.

Authors:  Gabi Tarcic; Shlomit K Boguslavsky; Jean Wakim; Tai Kiuchi; Angela Liu; Felicia Reinitz; David Nathanson; Takamune Takahashi; Paul S Mischel; Tony Ng; Yosef Yarden
Journal:  Curr Biol       Date:  2009-11-17       Impact factor: 10.834

10.  Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activity.

Authors:  Alexander Nyström; Zabeena P Shaik; Donald Gullberg; Thomas Krieg; Beate Eckes; Roy Zent; Ambra Pozzi; Renato V Iozzo
Journal:  Blood       Date:  2009-09-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.